Overview The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED) Status: Completed Trial end date: 2007-01-01 Target enrollment: Participant gender: Summary A study to test the effects of study drug (MK 0633) on patients with Atherosclerotic disease Phase: Phase 2 Details Lead Sponsor: Merck Sharp & Dohme Corp.